索引于
  • 学术期刊数据库
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 中国知网(CNKI)
  • 西马戈
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • 普布隆斯
  • 米亚尔
  • 大学教育资助委员会
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面

抽象的

Human Papilloma Virus Vaccine in Indian Settings: Need of the Hour

Akanksha Rathi, Suneela Garg and GS Meena

Cervical cancer is a major public health challenge accounting for a fifth of the global incidence and mortality. India has a population of 432.20 million women aged 15 years and above who are at risk of developing cervical cancer. The factors leading to high prevalence of cervical cancer in India are many. The high mortality due to the disease is mainly due to lack of awareness and absence of organized screening programs. India needs to take a leaf out of the book of 58 countries that have included Human Papilloma Virus (HPV) vaccine in their national immunization schedule so that the prevalence of this cancer can be brought down. Simultaneously, a need of organized screening programs throughout the country cannot be ignored.